Tech Company Financing Transactions
Glyphic Biotechnologies Funding Round
Glyphic Biotechnologies closed a $6 million Seed financing round on 7/28/2021. Backers included OMX Ventures, ARTIS Ventures and Axial.
Transaction Overview
Company Name
Announced On
7/28/2021
Transaction Type
Venture Equity
Amount
$6,025,000
Round
Seed
Investors
OMX Ventures (Lead Investor)
private investors (Trevor Martin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2261 Market St. 4403
San Francisco, CA 94114
USA
San Francisco, CA 94114
USA
Phone
Undisclosed
Website
Email Address
Overview
At Glyphic Biotechnologies, we are creating the protein revolution for which scientists and researchers have been waiting. Our team is comprised of talented scientists, engineers, and people who care about changing the underlying engines of biomedical discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Yang
Chief Technical Officer
Daniel Estandian
Browse more venture capital transactions:
Prev: 7/28/2021: PsiQuantum venture capital transaction
Next: 7/28/2021: At-Bay venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs